\section{Simple PK model for Remdesivir and GS-443902}\label{sup:sec:pk_params}
\input{remdesivir/app_pk_model}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\section{Table of parameters from Sego \emph{et. al}}\label{sup:remdes:sec:sego_params}%sup:remdes:sec:sego_params
\input{remdesivir/app_sego_param_table}
% \clearpage
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\section{Quantitative metrics of treatment outcome}\label{sup:remdes:sec:quantify_results}
\input{remdesivir/app_quantitative_metrics}
% \clearpage
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\section{Instructions for running the multiscale CompuCell3D simulations and for analyzing the results}\label{sup:sec:cc3d_instructions}
\input{remdesivir/app_instructions}
% \clearpage

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\section{Supplementary results for the untreated simulations with different initial conditions}\label{sup:remdes:sec:untreated-extra}
\input{remdesivir/app_untreated_results}
% \clearpage

\section{Supplementary results from treatment initiation delay, antiviral potency, and GS-443902 half-life variation}\label{sup:remdes:sec:extra_figures}

\input{remdesivir/app_results}
% \clearpage
\section{Supplementary results for viral production metabolism rate correlation}\label{sup:remdes:sec:super_spreaders}
\input{remdesivir/app_met_rate_correlation}
% \clearpage